Orthofix Medical Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Orthofix Medical stock has a consensus rating of "Buy" and an average price target of $15. The average 1-year stock price forecast is 59.57% higher than the current stock price, while the lowest is $12 (+27.66%) and the highest is $18 (+91.49%).

Price Target: $15 (+59.57%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$12	$15	$15	$18
Change	+27.66%	+59.57%	+59.57%	+91.49%

Analyst Ratings

The average analyst rating for Orthofix Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	2	2	2	2
Buy	1	1	1	1	1	1
Hold	1	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	6	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Petusky Barrington	Barrington	Buy Maintains $17 → $15	Buy	Maintains	$17 → $15	+59.57%	May 22, 2026
Thomas Stephan Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $18 → $15	Buy	Maintains	$18 → $15	+59.57%	May 22, 2026
Caitlin Roberts Canaccord Genuity	Canaccord Genuity	Buy Reiterates $20 → $18	Buy	Reiterates	$20 → $18	+91.49%	May 22, 2026
Mathew Blackman TD Cowen	TD Cowen	Hold Reiterates $14 → $12	Hold	Reiterates	$14 → $12	+27.66%	May 21, 2026

Financial Forecast

Revenue This Year

843.71M

from 822.31M

2.60%

from 822.31M

Revenue Next Year

887.48M

from 843.71M

5.19%

from 843.71M

EPS This Year

0.19

from 0.49

-61.02%

from 0.49

EPS Next Year

0.71

from 0.19

273.68%

from 0.19

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	464.48M	460.71M	746.64M	799.49M	822.31M	843.71M
Revenue Growth	14.25%	-0.81%	62.06%	7.08%	2.85%	2.60%
Gross Profit	349.57M	337.17M	522.32M	558.07M	576.88M	603.25M
Gross Margin	75.26%	73.18%	69.96%	69.80%	70.15%	71.50%
Operating Income	-134.00K	-30.47M	-105.77M	-65.53M	-57.61M	-34.65M
Net Income	-38.38M	-19.75M	-151.40M	-126.00M	-92.19M	-47.49M
EPS	-	-	-	-	0.49	0.19
EPS Growth	-	-	-	-	5,041.35%	-61.02%
Forward PE	35.26	21.88	-	-	-	49.47
Free Cash Flow	20.23M	-36.18M	-140.87M	55.42M	27.32M	-12.44M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	855.0M
Avg	843.7M
Low	837.6M

Revenue Growth

Revenue Growth	2026	2027	2028
High	4.0%
Avg	2.6%
Low	1.9%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	0.19
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-61.0%
Low	-